MY143870A - Molecular dispersions of drospirenone - Google Patents

Molecular dispersions of drospirenone

Info

Publication number
MY143870A
MY143870A MYPI20050960A MYPI20050960A MY143870A MY 143870 A MY143870 A MY 143870A MY PI20050960 A MYPI20050960 A MY PI20050960A MY PI20050960 A MYPI20050960 A MY PI20050960A MY 143870 A MY143870 A MY 143870A
Authority
MY
Malaysia
Prior art keywords
drospirenone
compositions
solid
molecular dispersions
gastro
Prior art date
Application number
MYPI20050960A
Other languages
English (en)
Inventor
Adrian Funke
Torsten Wagner
Original Assignee
Bayer Schering Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Schering Pharma Ag filed Critical Bayer Schering Pharma Ag
Publication of MY143870A publication Critical patent/MY143870A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/007Pulmonary tract; Aromatherapy
    • A61K9/0073Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/107Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1629Organic macromolecular compounds
    • A61K9/1635Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2072Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4858Organic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4866Organic macromolecular compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7007Drug-containing films, membranes or sheets

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Otolaryngology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
MYPI20050960A 2004-03-10 2005-03-09 Molecular dispersions of drospirenone MY143870A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP04075713 2004-03-10

Publications (1)

Publication Number Publication Date
MY143870A true MY143870A (en) 2011-07-15

Family

ID=34928104

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI20050960A MY143870A (en) 2004-03-10 2005-03-09 Molecular dispersions of drospirenone

Country Status (12)

Country Link
CN (1) CN1980636A (sr)
AR (1) AR048002A1 (sr)
DE (1) DE602005022952D1 (sr)
GT (1) GT200500044A (sr)
MY (1) MY143870A (sr)
PA (1) PA8625901A1 (sr)
PE (1) PE20060004A1 (sr)
RS (1) RS50975B (sr)
SV (1) SV2005002043A (sr)
TW (2) TW200840587A (sr)
UA (1) UA90263C2 (sr)
UY (1) UY28802A1 (sr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106109420B (zh) * 2016-08-11 2018-07-06 吴启旸 依普利酮固体分散体及其制剂

Also Published As

Publication number Publication date
TW200609000A (en) 2006-03-16
DE602005022952D1 (de) 2010-09-23
SV2005002043A (es) 2005-11-04
CN1980636A (zh) 2007-06-13
AR048002A1 (es) 2006-03-15
PE20060004A1 (es) 2006-02-16
TW200840587A (en) 2008-10-16
UA90263C2 (en) 2010-04-26
PA8625901A1 (es) 2006-07-03
GT200500044A (es) 2005-10-31
UY28802A1 (es) 2005-10-31
RS50975B (sr) 2010-10-31

Similar Documents

Publication Publication Date Title
IL177893A0 (en) Compositions comprising drospirenone molecularly dispersed
CR8630A (es) Solidos supersaturados estabilizados de drogas lipofilicas
WO2007027941A3 (en) Compositions and methods for preparation of poorly water soluble drugs with increased stability
MA37809B1 (fr) Administration de médicament biodégradable pour compositions hydrophobes
WO2007149406A3 (en) Modified coagulation factor ix polypeptides and use thereof for treatment
WO2012054500A3 (en) Compositions for drug administration
IL187813A0 (en) Pharmaceutical compositions of a neuroactive steroid and uses thereof
WO2008021368A3 (en) Compositions and methods for neuroprotection
FR2878158B1 (fr) Forme pharmaceutique orale, microparticulaire solide concue pour eviter le mesusage
WO2009048940A3 (en) Diacerein pharmaceutical formulations
MY143870A (en) Molecular dispersions of drospirenone
WO2011119649A3 (en) Pharmaceutical compositions containing berberine for treatment or prevention of weight gain and obesity associated with anti-psychotic drugs
WO2006128120A3 (en) Novel lapachone compounds and methods of use thereof
WO2007135295A3 (fr) Derives de 2-alcoxy-3,4,5-trihydroxy-alkylamide, leur préparation, compositions les contenant et utilisation
UA87838C2 (ru) Стабилизированные перенасыщенные твердые растворы липофильных лекарствнных средств
CU20060177A7 (es) Soluciones sólidas supersaturadas estabilizadas de drogas esteroides
TH135239A (th) องค์ประกอบทางเภสัชกรรมประเภทของแข็งซึ่งประกอบรวมด้วยแอมโลดิพีนและโลซาร์แทน
MY148088A (en) Stable nanoparticle formulations